Condition: Mitral Regurgitation · Mitral Insufficiency · Mitral Valve Incompetence · Sponsor: 4C Medical Technologies, Inc.
This is a prospective, single arm, multicenter, clinical trial designed to evaluate the safety and performance of the AltaValve System for the treatment of mitral regurgitation in a targeted patient population.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Abrazo Arizona Heart Hospital | Phoenix, Arizona, United States | Recruiting |
| Dignity Health; St. Joseph's Hospital and Medical Center | Phoenix, Arizona, United States | Recruiting |
| TMC Healthcare | Tucson, Arizona, United States | Recruiting |
| Sutter Bay Hospitals | San Francisco, California, United States | Recruiting |
| Los Robles Hospital & Medical Center | Thousand Oaks, California, United States | Recruiting |
| Cardiovascular Institute of the South | Houma, Louisiana, United States | Recruiting |
| MedStar Health Research Institute, Inc. | Columbia, Maryland, United States | Recruiting |
| William Beaumont Hospital | Royal Oak, Michigan, United States | Recruiting |
| Minneapolis Heart Institute Foundation | Minneapolis, Minnesota, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| Washington University | St Louis, Missouri, United States | Recruiting |
| AHS Hospital Corp. | Morristown, New Jersey, United States | Recruiting |
+ 17 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06465745